
Sign up to save your podcasts
Or


Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. However, other issues have contributed to the lack of supply and influencers have promoted weight loss supplements for years. So why is TGA looking into the particular promotion of Ozempic?
In this episode we speak to public health advisor on nutrition, Professor Tim Gill, to find out what’s different about the promotion of this specific drug.
Headlines:
Follow The Briefing:
Instagram: @thebriefingpodcast
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU
See omnystudio.com/listener for privacy information.
By LiSTNR3.9
88 ratings
Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. However, other issues have contributed to the lack of supply and influencers have promoted weight loss supplements for years. So why is TGA looking into the particular promotion of Ozempic?
In this episode we speak to public health advisor on nutrition, Professor Tim Gill, to find out what’s different about the promotion of this specific drug.
Headlines:
Follow The Briefing:
Instagram: @thebriefingpodcast
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU
See omnystudio.com/listener for privacy information.

54 Listeners

807 Listeners

93 Listeners

183 Listeners

368 Listeners

2 Listeners

330 Listeners

33 Listeners

45 Listeners

157 Listeners

71 Listeners

3 Listeners

96 Listeners

127 Listeners

337 Listeners

143 Listeners

169 Listeners

0 Listeners

20 Listeners

0 Listeners

32 Listeners

8 Listeners

275 Listeners

71 Listeners

6 Listeners

101 Listeners

42 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

22 Listeners